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The  differentiative  pathway  traversed  by  the  B  lymphocyte  in  response  to  an 
antigen is accompanied by the appearance of a number of a different constant region 
surface isotypes. Anti-isotype suppression  studies  have shown that neonatal suppres- 
sion with anti-/~ antibody leads not only to the failure of IgM-bearing cells to appear 
in the spleens of mice, but also to a  failure of IgG bearing cells to develop (1-3). This 
may suggest a maturational pathway from pre-B to plasma cell in which the/~-bearing 
B  lymphocyte is  the  precursor  cell  for those  ceils  bearing  6  and  y  chains  (3).  The 
failure  of 3'a  to  be  normally  expressed  in  the  serum  of immune  CBA/N  mice  (4) 
suggests  that  the  maturation  sequence  (5)  may be regulated  by complex biological 
mechanisms. 
Three T  cell alloantigens, Tthy  a, Tind  a, and Tsu  a, have been described (6-10). The 
map position of the genes coding for these antigens,  proximal  to the  Igh-1  locus on 
chromosome  12,  has led to the hypothesis that these alloantigens  represent  multiple 
isotypes  of the  T  cell  receptor  for antigen  (9).  Alternatively,  it  is  possible  that  the 
region tentatively named IgT-C is a  gene complex encoding T  cell-specific differen- 
tiation  antigens.  Ontogenetic  studies  have  indicated  a  maturational  sequence  of 
Tthy  a, Tind  d, Tsu  a (10). The order of appearance of the alloantigens on immunocom- 
petent  cells,  as  well  as  the  failure  to  demonstrate  Tthy  a  on cells  in  the  periphery, 
suggested the possibility that  the cell bearing Tthy  a may be the precursor  for those 
bearing Tind  a and Tsu  d. The studies outlined here explore that possibility. 
Materials  and Methods 
Mice.  C.AL-20 (H-2  d,  Igh-1  d)  allotype congenic mice on  a  BALB/cAnN (H-2  d,  Igh-1  a) 
background were developed by Michael Potter (National Institutes of Health, Bethesda, MD) 
and have been bred within our animal facility at Tufts University since 1978. 
Treatment of Neonatal C.AL-20 Mice with Anti-Tthy ~.  Monoclonal antibody recognizing Tthy  d 
(17IIC6) (8) was purified from ascites  fluid by (NH4)2SO4 precipitation, dialyzed, sterilized by 
Millipore  filtration,  and  stored  at  -20~C.  Mice were  injected  intraperitoneally  with  10 /Lg 
antibody within 24 h of birth. Injections were continued at 48 -h intervals until the mice were 
killed between days 35 and 45, mimicking the protocol used to deplete/l-bearing B cells (2, 11). 
* Supported by grants AI 15262 and AI 17442 from the National Institutes of Health. 
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Given a half-life of 5 d for mouse IgM, these mice should have circulating levels of anti°Tthy 
antibody at the time of bioassay. 
Antigen Priming of Lymph  Nodes.  Keyhole limpet hemocyanin (KLH) a (Calbiochem, San 
Diego,  Ca) was modified with picrylsulfonic acid (12). Antigen (50/~g  in phosphate-buffered 
saline [PBS]) was emulsified in 50/~1 Freund's adjuvant (Difco Laboratories, Detroit, MI) and 
injected into the footpads of adult animals on days 0 and -7. The draining popliteat lymph 
nodes were  removed on day  10 and used as targets for antibody-mediated complement lysis 
(10). 
Amplification of Antibody-mediated Cell Lysis by Fluorescein Isothiocyanate (FITC)-modified Monoclonal 
Antibody and Mouse Anti-FITC Immunoglobulin.  Monoclonal antibody was  collected  from  the 
ascites  fluid of mice primed with pristane and inoculated with hybrids of P.3U1 and BALB/ 
cAnN anti-C.AL-20 immune cells (6). Ammonium sulphate precipitated protein (10 mg) was 
modified by incubating with 0.5 M sodium carbonate (pH 9.5, containing i00 #g FITC) for  1 
h  at  4°C.  Labeled  protein  was  eluted  from  a  G-25  Sephadex  column in  0.i  M  sodium 
phosphate. Antibody was stored at 4°C in 0.04 M NAN3. Limiting dilutions of FITC-modified 
antibody were incubated with thymocytes from either C.AL-20 or BALB/c animals for 30 min 
at 4°C. Affinity-purified  mouse antibody specific for FITC was incubated with washed cells for 
30 min at 4°C without NaNa, and pelleted cells were resuspended in selected rabbit complement. 
After incubation  at 37°C for 45 rain, cells were washed and stored at 4°C. Cell lysis was scored 
visually by eosin dye exclusion. FITC-modified anti-Tthy  d, Tind  d, and Tsu  d were used at a 
concentration of 0.01/tg/10  s cells. Data are expressed  as cytotoxic index, calculated as follows: 
[(percent cells killed, experimental -  percent cells killed, complement (C') alone)/(percent cells 
killed, anti-Thy-l.2 -  percent cells killed, C' alone)] ×  100. Base  line studies describing the 
distribution of these antigens on cells in lymphoid organs of normal mice have been commu- 
nicated (10). 
Adsorption.  Monoclonal antibody modified with FITC (0.2/~g) was incubated with limiting 
numbers (5 ×  105-2 ×  107) of lymphoid cells from normal or anti-Tthy  d treated mice for 30 
rain at  4°C.  Cells  were  then  removed  by  centrifugation and  the  adsorbed  antibody was 
evaluated in the standard cytotoxicity assay described above. 
Fluorescent Analysis  of Cell Surface Antigens.  Cells  prepared  from  spleen  or  thymus  were 
suspended in PBS containing 2% horse serum and 0.04M NAN3. 1 X  l0  s cells were incubated 
with biotinylated monoclonal antibodies specific  for  Lyt-l.2, Lyt-2.2, and Thy-l.2 (Becton, 
Dickinson & Co., Sunnyvale, CA) or rabbit anti-mouse Ig (Fab')2 fragments for 30 min at 4°C 
(6). Cells were washed and resuspended in fluoresceinated avidin (Vector Laboratories, Burlin- 
game, CA) or goat anti-rabbit Ig (Meloy Labs, Springfield, VA), respectively, for 30 min at 
4°C. Cells were then washed and scored for membrane fluorescence in a cytoflurograf (System 
50H, Ortho Diagnostic Systems). This instrument is a single-cell measurement system using an 
argon laser beam excitation source,  set  at 488  nm and producing 1 W  of light output. The 
fluorescence emitted by stained cells was collected and filtered with a 510-540 nm bandpass 
filter (Schott Optical Glass Inc., Duryea, PA). The signals produced by the photomultipliers in 
response to collected, focused  fluorescence from each cell were integrated and represented as 
histograms, with the number of events plotted against increasing intensity of the signal. Data 
represent  the  spectrum  and  frequency of fluorescence of each  population analyzed.  The 
fluorescence histograms were gated by the light scattered at low angles to the incident beam, to 
exclude fluorescence from debris and dead cells. 
Results 
Tthy a Alloantigen  Expression  is  Depressed  in  Neonatally  Modulated Animals.  Previous 
studies (10)  have shown that Tthy  d appears in the neonatal thymus between 1 and 2 
d  after birth, although adult levels are not attained until approximately 21  d  of age. 
Expression  of Tthy  a  was  monitored  in  adult  animals that  had  received  repeated 
injections beginning within 24 h  of birth with a  monoclonal antibody (17IIC6,/tk) 
1Abbreviatwns used in this paper: FITC, fluorescein isothiocyanate; KLH, keyhole limpet hemocyanin; 
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TABLE  I 
Tthy a Alloantigen Expression in the Thymus of Anti-Tthy Ne~natally 
Modulated Mice* 
Animal number  Igh-1  Nconatal:~  Cytotoxic index§ +--_ 
anti-Tthy  SEM 
Experiment 1 
C.AL-20 control  d  -  22 4- 3 
BALB/c control  a  -  1 4- 0 
C.AL-20  1-1 (Exp)  d  +  7 +_ 1 
C.AL-20 1-2 (Exp)  d  +  3 4- 2 
C.AL-20  1-3 (Exp)  d  +  3 4- 2 
C.AL-20  1-4 (Exp)  d  +  2 4- 1 
Experiment 2 
C.AL-20 control  d  -  25 4- 3 
BALB/c control  a  -  5 4- 2 
C.AL-20 2-1 (Exp)  d  +  7 _  1 
C.AL-20  2-2 (Exp)  d  +  2 +  1 
C.AL-20 2-3 (Exp)  d  +  2 +_ 1 
C.AL-20 2-4 (Exp)  d  +  6 4- 2 
* Data represent eight experimental animals from three separate litters.  Ex- 
periments were performed on two days.  Assay was antibody-mediated cyto- 
toxicity as described  in Materials and Methods. 
~: Mice were treated with  a  monoclonal antibody  recognizing Tthy  a as  de- 
scribed in Materials and Methods. 
§ Cytotoxic index =  [(percent  dead, anti-Tthy  a -  percent dead, C' alone)/ 
(percent dead, anti-Thy- 1.2 -  percent dead, C' alone)] ×  100. Data represent 
the average of duplicate samples. 
specific  for  this  antigen.  The  percentage  of Tthya-bearing  ceils  in  the  thymus  of 
neonatally  treated  and  normal  age-matched  control  animals  was  assessed  by  a 
cytotoxicity  assay  using  FITC-modified  Tthya-specific  monoclonal  antibodies 
(17IIC6)  plus affinity purified  mouse  anti-FITC  antibodies  and  complement  (Table 
I). The  frequency of Tthy a positive cells was markedly  decreased  in treated  animals, 
representing  a  mean  cytotoxic  index  of 4  compared  with  23  in  control  thymocyte 
populations.  This  observation  suggests  that  treatment  of  newborn  animals  with 
antibodies specific for Tthy a  results  in  the elimination of a  substantial  portion of the 
Tthy a bearing thymocyte population.  Alternatively, anti-Tthy a antibody could act in 
vivo at the level of the antigenic determinant  itself, resulting in capping and clearance 
of the cell membrane  without lysing the cell bearing that  determinant.  In either case, 
we would detect fewer numbers of Tthy d positive thymocytes. Although our results do 
not distinguish  between the two possibilities, the monoclonal antibody  used for the in 
vivo modulation  ofTthy d (17IIC6)  is an IgM antibody,  and  therefore  it is likely that 
its  attachment  to  the  surface  of Tthya-bearing  cells  would  result  in  complement- 
mediated  lysis of the cell and  not simple antigenic blockade. 
Newborn  animals  treated  with  anti-Tthy a  but  not  its  allelic  counterpart,  anti- 
Tthya, 2 showed  decreased  levels of Tthy  antigen  expression  (Table II).  Because both 
of these monoclonal antibodies share the same isotope (/t, x), Tthy  loss is probably not 
due to stress  factors  resulting  from the immunization  protocol.  Both  anti-Tthy"  and 
F. L. Owen. Products  of the IgT-C region of chrornosome  12. Allelic expression ofTthy  a and Tthy  a in 
the (BALB/c × C.AL-20)F1 heterozygote.  Manuscript in preparation. SUSAN  K.  KEESEE  AND  FRANCES  L.  OWEN 
TABLE  II 
Neonatal Pretreatment with Anti- Tthy '~ or Anti- Thy a 
89 
Group hum-  Antibody treatment:~  Cytotoxic index§ - 
ber*  SEM 
1  Anti-Tthy  a  14 ±  2 (5) 
2  Anti-Tthy  a  2 ±  1 (3) 
3  Control  18 ±  1 (5) 
* Groups  represent  experimental  animals  from  separate  litters.  Assay  was 
antibody-mediated cytotoxicity as described in Materials and Methods. 
:~ Mice were treated with monoelonal antibodies recognizing Tthy" (C.B. 13.10) 
or  Tthy  a  (171IC6)  as  described  in  Materials  and  Methods.  Anti-Tthy  a 
(C.B. 13.10) is described in Results. 
§ Cytotoxic  index  =  [(percent  dead,  anti-Tthy  a  -  percent  dead,  C' alone)/ 
(percent dead, anti-Thyl.2 -  percent dead, C' alone)] ×  100. Data represent 
the average of duplicate samples. Numbers in parentheses represent number 
of  mice  per  group.  Each  animal  was  evaluated  individually  and  data 
represent the mean of five separate animals. 
TABLE  III 
Flow Cytometer Analysis of Lyt-l.2, Lyt-2.2,  Thy-l.2, and slg Expression In Anti-Tthy d NeonataUy 
Modulated Mice * 
Animal number  sIg 
Number of positive cells  ±  SEM§ 
Thy- 1.2  Lyt- 1.2  Lyt-2.2 
Experiment 1  Control  0.9 ±  0  98 ---+ 0  95 +  2  78 +  1 
Thymus  1.1  5+  1  98±0  95+4  73+8 
1.2  4+  1  94±  1  95+  I  59:1:-+6 
1.3  1 ±0  99±0  95±0  80±  1 
1.4  2±0  98±0  95±0  76±  1 
Experiment 2  Control  1 ±  0  95 ±  1  95 ±  1  64 :!: 3 
Thymus  2.1  1 ±0  98±0  95±  1  75±2 
2.2  0.9 ±  0  97 ±  0  95 ±  3  56 ±  2 
2.3  0.4 ±  0  97 ±  0  95 ±  3  65 ±  0 
2.4  0.9±0  97±0  95±  1  58±2 
Experiment 1  Control  33 ±  2  43 ±  1  38 ±  1  20 -  0 
Spleen  1.1  53 ±  0  34 ±  2  31  ±  1  18 ±  2 
1.2  52±2  38±  1  31±  1  18±2 
1.3  47±  I  43±0  38±0  18±  1 
1.4  40±7  43±0  43±  1  21  ±0 
Experiment 2  Control  32 ±  1  36 ±  1  19 ±  0  15 ±  0 
Spleen  2.1  43 ±  3  38 ±  1  36:1: ±  1  19 ±  2 
2.2  28±  1  39±  1  28±  14  11~±  1 
2.3  31  ±3  36±0  21±0  14+0 
2.4  31±  1  39±  1  20±0  18±3 
* Data represent eight experimental animals from three separate litters.  Experiments were performed on 
different days. Data were collected on an Ortho Diagnostics Cytofluorograf Flow Cytometer as described 
in Materials and Methods. 
No significant differences were observed in fluorescence patterns of neonatally  modulated  animals as 
compared with normal controls. These three animals represent unexplained individual variations. 
§ Percent  positive ceils  was determined as described  in Materials  and Methods from duplicate samples. 
Nonspecific staining for FITC-avidin  and  FITC-rabbit anti-mouse Ig were as  follows:  FITC avidin, 
spleen, 5.8 ±  2%, thymus, 1.9 ±  0.5%, FITC-RAMIg, spleen, 0.8  ±  0.8%, thymus, 0.4  ±  0.2%. Standard 
errors are rounded to the nearest whole number. 90  NEONATAL MODULATION OF Tthy 
anti-Tthy  a were ammonium sulphate-precipitated proteins raised in the ascites from 
pristane primed mice injected with P.3Ul-derived hybrid cells. 
Modulation  of Tthy d Does Not Affect Expression  of Lyt-Z.2, Lyt-2.2,  Thy-l.2,  or Surface Ig 
(sIg).  Surface  expression  of the  T  cell  antigens  Lyt-l.2,  Lyt-2.2,  Thy-l.2,  and  a 
marker for B ceils, surface membrane immunoglobulin, was studied by flow cytometer 
analysis of the spleen and thymus cells of neonatally modulated animals. The results 
of this  study  (Table  Ill)  indicated  no  significant  differences  between  anti-Tthy  a- 
treated or control  animals in the percentages of cells bearing any of these antigens. 
We would conclude that the cell bearing Tthy  d represents a subpopulation of cells in 
the thymus, and that it does not have a direct role in regulating the differentiation of 
those cells characterized by various Ly phenotypes. The fact that  we did  not  see a 
decrease in the total number ofT cells by the criteria of cell sorter analysis (Thy 1.2) 
or  direct  counts  (an  average of 8.3  ×  10  7 vs.  7.4  X  10  7 cells/thymus,  anti-Tthy  d 
treated,  or  control,  respectively)  in  the  thymuses  of  treated  animals  which  had 
demonstrated  a  loss  of Tthy  a  expression  suggests  the  possibility  that  homeostatic 
mechanisms existing in vivo resulted in a compensatory increase in a different T  cell 
subpopulation  in these animals. This phenomenon  has been observed for B  cells in 
both allotype and idiotype suppression studies  (13,  14). 
An examination of the histograms generated by flow cytometer analysis (Figs.  1-3) 
revealed  that  surface  staining  characteristics  of experimental  and  control  animals 
were virtually identical for all the antigens studied.  This suggested that not only the 
number of cells  but  also  the  surface  determinant  density  was  unaltered  by Tthy  a 
antigenic modulation,  slg staining of thymus and spleen was not elevated. It is thus 
unlikely that IgM antibodies  (anti-Tthy  d) circulate and block Tthy  a in vitro. 
Tind a  and  Tsu a  Alloantigen  Expression  Is  Altered  in  Neonatally  Modulated  Animals. 
Studies  by Owen  (10)  have indicated  that  the  T  cell  alloantigens  Tind  a and  Tsu  a 
appear sequentially in peripheral lymphoid organs of neonatal mice, on days 2-3 and 
5-6, respectively. Tthy  a is expressed in the bone marrow and thymus, and  its early 
appearance (days 1-2) suggested that the cell bearing this antigen may be a precursor 
for the cells expressing Tind  a and Tsu  d. Expression of Tind  a and Tsu  a was monitored 
in neonatally treated mice by indirect  adsorption of monoclonal antibodies  specific 
for these antigens. Spleen cells from mice that had been treated with anti-Tthy  a were 
used  to adsorb FITC-modified monoclonal  antibodies  specific for Tind  d and  Tsu  d. 
The adsorbed antibodies were then evaluated in the standard complement-mediated 
cytotoxicity assay, using trinitrophenyl-KLH-primed lymph node cells as targets (Fig. 
4). Tthy  a expression was similarly measured by adsorbing the appropriate antibody 
with  increasing numbers of thymocytes and then scoring the adsorbed antibody on 
thymus cells.  Tind  d and  Tsu  a expression was  substantially  depressed in  anti-Tthy  a 
neonatally modulated  animals.  An examination of panels A  and  B  of Fig.  4 shows 
that the number of cells from modulated animals required to remove antibody activity 
was at  least  10-fold greater than  that  of age-matched controls. These data  provide 
additional  evidence  that  treatment  of  neonatal  mice  with  anti-Tthy  a  results  in 
decreased  numbers  of Tthy-bearing  cells,  rather  than  modulation  or  masking  of 
determinants without eliminating cells expressing Tthy. We have established in earlier 
experiments (8) that Tthy, Tind, and Tsu do not co-modulate at the cell surface. The 
monoclonal antibodies do not compete for the same site(s), suggesting that antigeni- SUSAN  K.  KEESEE  AND  FRANCES  L,  OWEN  91 
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FIG.  1.  Fluorescence analysis of spleen cells from anti-Tthyd-treated  and control mice.  Panel A, 
anti-Tthya-treated animals; panel B, control animals. 
tally unrelated  determinants are depleted.  Our results suggest that the cell bearing 
Tthy  d is required for the later maturation of cells expressing Tind  d and Tsu  d. 
Discussion 
In the studies reported here, we have used an immunization protocol analogous to 
that used to achieve chronic # suppression in neonatal mice with the goal of removing 
T  lymphocytes bearing the Tthy  d alloantigen. Tthy  d is found on a  subpopulation of 
thymocytes in (Igh-I  d'~) mice but is not expressed at detectable levels on peripheral T 
cells  (8,  10).  This  alloantigen  is  one  of a  group  of allotype-specific T  cell  surface 
antigens  reported  in  previous  work  from  this  laboratory.  Recently,  it  has  been 
demonstrated  that  Tthy  a  alloantigen  expression  precedes  that  of two  other T  cell 
alloantigens, Tind  d and Tsu  d, in ontogeny (10). This result, and the fact that Tthy  d 
expression precedes that  of Tind  d or Tsu  d on  immunocompetent T  cells,  led  us to 
investigate a  possible precursorial  relationship between  the cell bearing Tthy  d and 92 
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FIG.  2.  Fluorescence analysis of thymocytes from anti-Tthya-treated and control mice. Panel A, 
d  anti-Tthy  -treated animals; panel B, control animals. 
those  expressing  Tind  a  and  Tsu d.  Treatment  of newborn  mice  with  a  monoclonal 
antibody recognizing Tthy  a resulted  either in the complete abrogation or the severe 
depletion of thymocytes bearing this alloantigen  (Table I). Tthy  d expression has been 
monitored  in  >30  suppressed  mice  and  in  each  case  there  has  been  significant 
depletion or the complete removal or Tthya-bearing cells. These results are consistent 
with,  but  do  not  prove,  the  conclusion  that  treatment  of mice  from  birth  with 
monoclonal anti-Tthy d antibody results in the removal of the thymocyte subpopula- 
tion expressing this alloantigen. The apparent loss of the Tthyqbearing T  lymphocyte 
in neonatally suppressed animals could have a trivial explanation in that the antibody 
recognizing Tthy  d (17IIC6) could block or mask the antigenic sites in such a way that 
they are not detected by our cytotoxicity assay. Such blocking could occur directly, or 
modulation  at  the cell surface could result  in capping and endocytosis of the Tthy  a 
antigenic  determinant.  However, the  fact  that  Tind  d- and Tsud-bearing cells  fail  to 
appear  in  the  peripheral  lymphoid  organs  of suppressed  animals  (Fig.  4)  argues SUSAN K. KEESEE AND FRANCES L. OWEN  93 
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FIG. 3.  sIg fluorescence  analysis of spleen cells from anti-Tthyd-treated  and control mice. 
strongly against  this possibility. It has been previously shown that  the monoclonal 
antibodies recognizing Tthy  d, Tind  a, and Tsu  d are non-cross-reacting (8). 3 Further- 
more, Tthy  a, Tind  d, and Tsu  d are expressed on largely nonoverlapping T  lymphocyte 
subpopulations (10). 
Cytofluorograph analysis of spleen and thymus cells from suppressed mice failed to 
show  any  alteration  in  levels  of Lyt  alloantigen  or  Thy-l.2  antigen  expression, 
indicating that the pathway including the Tthya-bearing cell is phenotypically distinct 
from that  involving the  development of various  Ly phenotypes.  Experiments per- 
formed on suppressed  mice  at  5,  10,  or  15  d  of age similarly  failed  to  show  any 
alteration  of Lyt-l.2, Thy-l.2, or sIg expression  (data  not  shown),  indicating that 
these two pathways develop independently from an early age. If in vivo compensation 
between T  cell subsets is obscuring a shift in Ly or Thy-l.2 antigen expression, then 
it must occur before the age of 5  d  postpartum.  The chromosomal location of the 
genes encoding the products of the IgT-C locus (chromosome 12)  (9) is distinct from 
those responsible for Lyt-l.2 (chromosome 19)  (15)  or Lyt-2.2 (chromosome 6)  (16). 
3  G. M. Spurll, M. Frye, L. Riendeau, A. Finnegan, and F. L. Owen.  A panel of monoclonal  antibodies 
specific for products of IgT-C. Manuscript in preparation. X
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Lyt-l.2 is expressed on virtually all T  lymphocytes (19). These findings suggest that 
the family of T  cell alloantigens  including  Tthy  d represents a  group of cell surface 
markers delineating aspects of T  cell development independent from those character- 
ized by Ly phenotype (18). 
The  results  of  this  study  are  consistent  with  the  hypothesis  that  the  T  cell 
alloantigens Tthy  a, Tind  a, and Tsu  a characterize a T  cell differentiation pathway in 
which  the  Tthya-bearing cell  is  a  precursor  for those  expressing  Tind  a  and  Tsu  a. 
Alternatively, Tthy  a could be a  surface marker for a  regulatory cell that governs the 
differentiation  of a  separate  precursor  into  cells  expressing  Tind  a  and  Tsu a.  We 
suggest that these three alloantigens may represent part of a group of T  cell constant 
region isotypes, or possibly a  collection of immunoglobulin gene complex-associated 
differentiation antigens, which  serve as cell surface markers for distinct  stages in T 
cell development. Although our results do not distinguish between these possibilities, 
it  is  worthwhile  to  note  the  parallel  between  these  studies  and  those  involving  B 
lymphocyte differentiation  in  the  mouse.  Kearney  et  al.  (19)  have  shown  that  B 
lymphocytes bearing sIgM precede those expressing sIgG. Studies involving suppres- 
sion in neonatal mice have demonstrated that removal of sIgM  + B lymphocytes also 
prevents the normal development of cells bearing any other surface immunoglobulin 
heavy chain isotype (1), whereas treatment of neonates with anti-8 antibodies results 
in a population of B cells that are phenotypically sIgM  + sIgD- (20). These and recent 
similar findings of Fultz et al.  4 have led to the hypothesis that the ordered appearance 
of the surface immunoglobulin isotypes characterize distinct developmental stages in 
B cell differentiation (21). 
The  availability  of  a  group  of  cell  surface  markers  for  distinct  subsets  of  T 
lymphocytes provides one the opportunity to examine in detail questions concerning 
the functional role of different T  cell subpopulations in various immune phenomena. 
Ceredig et  al.  (22)  have described  an immunologically mature,  Lyt 2 + thymus cell 
subpopulation that produces interleukin-2.  Both the cell size of this subset (medium) 
and its distribution  in the thymus (15%)  are consistent with the possibility that this 
population  of cells  represents  those  expressing  Tthy  a.  It  would  be  of interest  to 
determine whether anti-Tthy  a neonatally suppressed animals are capable of producing 
normal levels of interleukin-2. 
Chronic suppression studies involving B lymphocytes have been useful in discerning 
possible functional interrelationships which exist between the B and T  cell compart- 
ments of the immune response. Thus, Bottomly et al. (11) have shown that treatment 
of newborn mice with anti-# antibody leads to the disappearance of not only sIg  + B 
lymphocytes but also an antigen-specific T  helper cell required  for the expression of 
the T15 idiotype. Similarly, studies by Fultz and co-workers (23)  have indicated that 
chronic suppression of an IA  k specificity results  in  the depletion of surface IgM  + B 
lymphocytes as well as significantly decreased MLR responses. We have demonstrated 
an in vivo model involving chronic T  cell suppression. This model may be useful in 
the elucidation of the functional role(s) of various T  cell subsets. 
Summary 
The T  cell alloantigen Tthy  a appears on a  subpopulation of thymocytes in mice 
bearing the Igh-1  a or e heavy chain  haplotype.  Ontogenetic  studies  have suggested 
4 M. J. Fultz, I. Scher, F. D. Finkelman, P. Kincade, and J. J. Mond.  1982. Neonatal suppression with 
anti-Ia antibody. I. Suppression of murine B lymphocyte development.J. Immunol.  129:992. 96  NEONATAL  MODULATION OF Tthy 
that this antigen precedes the appearance of two other T  cell alloantigens in the same 
linkage group,  Tind  a  and  Tsu a.  The  purpose of this study was  to  determine  if the 
Tthy-bearing ceil is a  precursor for cells in the periphery expressing Tind and Tsu. 
C.AL-20 mice were  treated  at  48-h  intervals beginning on  the  day of birth with  a 
monoclonal  antibody recognizing Tthy.  Tthy  alloantigen expression, monitored  by 
cytotoxicity assays, was found to be significantly depressed in the thymuses of treated 
animals; Tind and Tsu  also failed to appear in the periphery. Treatment  with anti- 
Tthy caused no significant changes in frequency or surface intensity in the expression 
of surface Ig, Thy-l.2, Lyt-l.2, and  Lyt-2.2, as studied by cytofluorograph analysis. 
We conclude that  the T-thyd-bearing cells in the thymus represent a  subpopulation 
that  may be a  precursor for Tind  a- and Tsud-bearing cells. However, Tthya-bearing 
cells are more mature than the Thy-l.2 common T  cell precursor, pre-T. 
The expert assistance of Joan  McDowell of the MIT Cell Sorter Laboratory was helpful in 
completing these studies. 
Received  for publication 15 September 1982. 
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